Metabolic control and cost-effectiveness of prandial insulin therapy for patients with type 2 diabetes -: results of "PHAZIT"

被引：0
|
作者：
Kaiser, M
Häuser, C
Münscher, C
Potthoff, E
机构：
[1] Diabet Zentrum, Erfurt, Germany
[2] Novo Nordisk Pharma GmbH, Mainz, Germany
[3] MNC GmbH, Munster, Germany
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
839
引用
收藏
页码：A305 / A305
页数：1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF THERAPY CONVERSION FROM HUMAN SOLUBLE INSULIN TO INSULIN ASPART IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING
    Xu, Z. R.
    Ye, Q.
    Zhang, Y. Z.
    VALUE IN HEALTH, 2013, 16 (03) : A163 - A164
  • [12] Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
    Braendle, M.
    Erny-Albrecht, K. M.
    Goodall, G.
    Spinas, G. A.
    Streit, P.
    Valentine, W. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (08) : 501 - 515
  • [13] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Liu, C.
    Tao, L. B.
    Wang, F.
    VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [14] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    Lan, K.
    Wang, J.
    VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [15] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [16] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
    Saiyarsarai, P.
    Khosroshahi, Ghazizadeh A.
    Khedmati, J.
    Ghaffari, S.
    Soleymani, F.
    Seyyedifar, M.
    VALUE IN HEALTH, 2019, 22 : S576 - S576
  • [17] Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Mellitus
    Brown, Stephen T.
    Grima, Daniel Grima
    Sauriol, Luc
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1576 - 1587
  • [18] Cost-effectiveness and clinical outcomes of metformin or insulin add-on therapy in adults with type 2 diabetes
    Brown, RR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 : S24 - S27
  • [19] Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    McQueen R.B.
    Ellis S.L.
    Campbell J.D.
    Nair K.V.
    Sullivan P.W.
    Cost Effectiveness and Resource Allocation, 9 (1)
  • [20] Cost-effectiveness of treatment of type 2 diabetes
    Eastman, RC
    DIABETES CARE, 1998, 21 (03) : 464 - 465
12345